0001189724-16-000014.txt : 20160331
0001189724-16-000014.hdr.sgml : 20160331
20160331185801
ACCESSION NUMBER: 0001189724-16-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160331
DATE AS OF CHANGE: 20160331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RIGGS STEVEN
CENTRAL INDEX KEY: 0001189724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 161544523
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL INC
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-03-31
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001189724
RIGGS STEVEN
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP Operations
Common Stock
2016-03-31
4
X
0
683.0
46.53
A
2061
D
Common Stock
2016-03-31
4
S
0
683.0
105.0
D
1378
D
Common Stock
2016-03-31
4
X
0
1599.0
58.79
A
2977
D
Common Stock
2016-03-31
4
S
0
1599.0
105.0
D
1378
D
Common Stock
2016-03-31
4
X
0
17718.0
61.76
A
19096
D
Common Stock
2016-03-31
4
S
0
17718.0
105.0
D
1378
D
Non-Qualified Stock Option (right to buy)
46.53
2016-03-31
4
X
0
683.0
46.53
D
2022-02-01
Common Stock
683
0
D
Non-Qualified Stock Option (right to buy)
58.79
2016-03-31
4
X
0
1599.0
58.79
D
2024-02-24
Common Stock
1599
123401
D
Non-Qualified Stock Option (right to buy)
61.76
2016-03-31
4
X
0
17718.0
61.76
D
2023-02-06
Common Stock
17718
5906
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17,2016.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
Transaction is the exercise of a derivative security; see Column 2.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
By: Paula Darbyshire For: Steven C. Riggs
2016-03-31